Gallot G - Search Results

1

Effector memory alphabeta T lymphocytes can express FcgammaRIIIa and mediate antibody-dependent cellular cytotoxicity.

Clémenceau B, Vivien R, Berthomé M, Robillard N, Garand R, Gallot G, Vollant S, Vié H. Clémenceau B, et al. Among authors: gallot g. J Immunol. 2008 Apr 15;180(8):5327-34. doi: 10.4049/jimmunol.180.8.5327. J Immunol. 2008. PMID: 18390714

2

Long-term preservation of antibody-dependent cellular cytotoxicity (ADCC) of natural killer cells amplified in vitro from the peripheral blood of breast cancer patients after chemotherapy.

Clémenceau B, Gallot G, Vivien R, Gaschet J, Campone M, Vié H. Clémenceau B, et al. Among authors: gallot g. J Immunother. 2006 Jan-Feb;29(1):53-60. doi: 10.1097/01.cji.0000175686.13368.5c. J Immunother. 2006. PMID: 16365600

3

Antibody-dependent cellular cytotoxicity (ADCC) is mediated by genetically modified antigen-specific human T lymphocytes.

Clémenceau B, Congy-Jolivet N, Gallot G, Vivien R, Gaschet J, Thibault G, Vié H. Clémenceau B, et al. Among authors: gallot g. Blood. 2006 Jun 15;107(12):4669-77. doi: 10.1182/blood-2005-09-3775. Epub 2006 Mar 2. Blood. 2006. PMID: 16514054 Free article.

4

The T cell repertoire selected in vitro against EBV: diversity, specificity, and improved purification through early IL-2 receptor alpha-chain (CD25)-positive selection.

Ibisch C, Saulquin X, Gallot G, Vivien R, Ferrand C, Tiberghien P, Houssaint E, Vié H. Ibisch C, et al. Among authors: gallot g. J Immunol. 2000 May 1;164(9):4924-32. doi: 10.4049/jimmunol.164.9.4924. J Immunol. 2000. PMID: 10779803

5

Purification of Ag-specific T lymphocytes after direct peripheral blood mononuclear cell stimulation followed by CD25 selection. I. Application to CD4(+) or CD8(+) cytomegalovirus phosphoprotein pp65 epitope determination.

Gallot G, Vivien R, Ibisch C, Lulé J, Davrinche C, Gaschet J, Vié H. Gallot G, et al. J Immunol. 2001 Oct 15;167(8):4196-206. doi: 10.4049/jimmunol.167.8.4196. J Immunol. 2001. PMID: 11591740

6

T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.

Gallot G, Hamidou MA, Clémenceau B, Gaschet J, Tiberghien P, Ferrand C, Vivien R, Barbarot S, Coste-Burel M, Moreau A, Vié H. Gallot G, et al. Clin Immunol. 2006 Apr;119(1):79-86. doi: 10.1016/j.clim.2005.11.008. Epub 2006 Jan 4. Clin Immunol. 2006. PMID: 16386957

7

Viral DNA contamination is responsible for Epstein-Barr virus detection in cytotoxic T lymphocytes stimulated in vitro with Epstein-Barr virus B-lymphoblastoid cell line.

Berthomé M, Gallot G, Vivien R, Clémenceau B, Nguyen JM, Coste-Burel M, Vié H. Berthomé M, et al. Among authors: gallot g. Cancer Immunol Immunother. 2010 Dec;59(12):1867-75. doi: 10.1007/s00262-010-0913-2. Epub 2010 Aug 31. Cancer Immunol Immunother. 2010. PMID: 20809356 Free PMC article.

8

Selection of Epstein-Barr virus specific cytotoxic T lymphocytes can be performed with B lymphoblastoid cell lines created in serum-free media.

Gallot G, Vollant S, Vivien R, Clémenceau B, Ferrand C, Tiberghien P, Gaschet J, Robillard N, Vié H. Gallot G, et al. Clin Exp Immunol. 2006 Apr;144(1):158-68. doi: 10.1111/j.1365-2249.2006.03035.x. Clin Exp Immunol. 2006. PMID: 16542378 Free PMC article.

9

Preparation of genetically homogeneous antigen-specific thymidine kinase positive T-lymphocyte clones for the control of alloreactivity post-bone marrow transplantation.

Clémenceau B, Gallot G, Lemoine FM, Klatzmann D, Vié H. Clémenceau B, et al. Among authors: gallot g. Hum Gene Ther. 2004 Jun;15(6):542-52. doi: 10.1089/104303404323141999. Hum Gene Ther. 2004. PMID: 15212713

10

T-cell therapy using a bank of EBV-specific cytotoxic T cells: lessons from a phase I/II feasibility and safety study.

Gallot G, Vollant S, Saïagh S, Clémenceau B, Vivien R, Cerato E, Bignon JD, Ferrand C, Jaccard A, Vigouroux S, Choquet S, Dalle JH, Frachon I, Bruno B, Mothy M, Mechinaud F, Leblond V, Milpied N, Vié H. Gallot G, et al. J Immunother. 2014 Apr;37(3):170-9. doi: 10.1097/CJI.0000000000000031. J Immunother. 2014. PMID: 24598452 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters